Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study

por Price, Elizabeth, Bombardieri, Michele, Kivitz, Alan, Matzkies, Franziska, Gurtovaya, Oksana , Pechonkina, Alena, Jiang, Wendy, Downie, Bryan, Mathur, Anubhav, Mozaffarian, Afsaneh, Mozaffarian, Neelufar, Gottenberg, J Eric
Publicado 2022

Differential levels of IFNα subtypes in autoimmunity and viral infection

por Bondet, Vincent, Rodero, Mathieu P., Posseme, Céline, Bost, Pierre, Decalf, Jérémie, Haljasmägi, Liis, Bekaddour, Nassima, Rice, Gillian I., Upasani, Vinit, Herbeuval, Jean-Philippe, Reynolds, John A., Briggs, Tracy A., Bruce, Ian N., Mauri, Claudia, Isenberg, David, Menon, Madhvi, Hunt, David, Schwikowski, Benno, Mariette, Xavier, Pol, Stanislas, Rozenberg, Flore, Cantaert, Tineke, Gottenberg, J. Eric, Kisand, Kai, Duffy, Darragh
Publicado 2021